WO1994002611A3 - Recombinant human erythropoietin with altered biological activity - Google Patents
Recombinant human erythropoietin with altered biological activity Download PDFInfo
- Publication number
- WO1994002611A3 WO1994002611A3 PCT/US1993/007116 US9307116W WO9402611A3 WO 1994002611 A3 WO1994002611 A3 WO 1994002611A3 US 9307116 W US9307116 W US 9307116W WO 9402611 A3 WO9402611 A3 WO 9402611A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biological activity
- recombinant human
- human erythropoietin
- erythropoietin
- altered biological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93922677A EP0667903A1 (en) | 1992-07-28 | 1993-07-28 | Recombinant human erythropoietin with altered biological activity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92081092A | 1992-07-28 | 1992-07-28 | |
US07/920,810 | 1992-07-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994002611A2 WO1994002611A2 (en) | 1994-02-03 |
WO1994002611A3 true WO1994002611A3 (en) | 1994-03-31 |
Family
ID=25444454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/007116 WO1994002611A2 (en) | 1992-07-28 | 1993-07-28 | Recombinant human erythropoietin with altered biological activity |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP0667903A1 (en) |
WO (1) | WO1994002611A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153407A (en) * | 1992-07-28 | 2000-11-28 | Beth Israel Deaconess Medical Center | Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics |
US5614184A (en) * | 1992-07-28 | 1997-03-25 | New England Deaconess Hospital | Recombinant human erythropoietin mutants and therapeutic methods employing them |
US5830851A (en) * | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
US5773569A (en) * | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US6187564B1 (en) | 1997-07-10 | 2001-02-13 | Beth Israel Deaconess Medical Center | DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics |
US6165476A (en) * | 1997-07-10 | 2000-12-26 | Beth Israel Deaconess Medical Center | Fusion proteins with an immunoglobulin hinge region linker |
US6242570B1 (en) | 1997-07-10 | 2001-06-05 | Beth Israel Deaconess Medical Center | Production and use of recombinant protein multimers with increased biological activity |
AU8182298A (en) * | 1997-07-10 | 1999-02-08 | Beth Israel Deaconess Medical Center | Recombinant erythropoietin / immunoglobulin fusion proteins |
JP2002512039A (en) | 1998-04-22 | 2002-04-23 | コーネル リサーチ ファンデーション インク. | Canine erythropoietin gene and recombinant protein |
US6696411B1 (en) | 1998-04-22 | 2004-02-24 | Cornell Research Foundation, Inc. | Canine erythropoietin gene and recombinant protein |
US6703480B1 (en) | 1999-11-24 | 2004-03-09 | Palani Balu | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use |
JP5406710B2 (en) | 2006-05-19 | 2014-02-05 | グライコフィ, インコーポレイテッド | Erythropoietin composition |
WO2022054748A1 (en) * | 2020-09-10 | 2022-03-17 | 扶桑薬品工業株式会社 | Erythropoietin signaling inhibitor protein |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0409113A1 (en) * | 1989-07-20 | 1991-01-23 | BEHRINGWERKE Aktiengesellschaft | Human erythropoietin muteins, their production and their use |
WO1992021029A1 (en) * | 1991-05-10 | 1992-11-26 | Genentech, Inc. | Selecting ligand agonists and antagonists |
-
1993
- 1993-07-28 WO PCT/US1993/007116 patent/WO1994002611A2/en not_active Application Discontinuation
- 1993-07-28 EP EP93922677A patent/EP0667903A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0409113A1 (en) * | 1989-07-20 | 1991-01-23 | BEHRINGWERKE Aktiengesellschaft | Human erythropoietin muteins, their production and their use |
WO1992021029A1 (en) * | 1991-05-10 | 1992-11-26 | Genentech, Inc. | Selecting ligand agonists and antagonists |
Non-Patent Citations (3)
Title |
---|
CHERN, Y. ET AL.: "Structural role of amino acids 99-110 in recombinant human erythropoietin", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 202, no. 2, December 1991 (1991-12-01), BERLIN, DE, pages 225 - 229 * |
DUBÉ, S. ET AL.: "Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 263, no. 33, 25 November 1988 (1988-11-25), BALTIMORE, MD US, pages 17516 - 17521 * |
POWELL, J. ET AL.: "Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 83, no. 17, September 1986 (1986-09-01), WASHINGTON US, pages 6465 - 6469 * |
Also Published As
Publication number | Publication date |
---|---|
EP0667903A1 (en) | 1995-08-23 |
WO1994002611A2 (en) | 1994-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994002611A3 (en) | Recombinant human erythropoietin with altered biological activity | |
IL118201A0 (en) | Erythropoietin free of animal proteins processes for production and use thereof | |
AU560340B2 (en) | Rennin from recombinant dna | |
WO1998045456A8 (en) | 2-deoxyglucose-6-phosphate (2-dog-6-p) phosphatase dna sequences as selection markers in plants | |
NZ221119A (en) | Proteins with factor viii activity produced by microorganisms produced by genetic engineering | |
IL94361A0 (en) | Polypeptides,recombinant dna molecules and method of producing a human hemoglobin like protein | |
ATE90966T1 (en) | EXPRESSION OF PROTEIN-C. | |
AU573523B2 (en) | Functional human urokinase proteins | |
CA2033176A1 (en) | Growth hormone fusion proteins | |
AU3192889A (en) | T cell activation markers | |
CA2147372A1 (en) | Multidrug resistance gene | |
AU7750487A (en) | Biological control of damping off and root rot and inoculum preparation therefor | |
WO1994024160A3 (en) | Erythropoietin muteins with enhanced activity | |
ATE93272T1 (en) | EXPRESSION OF PROTEIN C | |
AU3329989A (en) | Viper venom polypeptides and genetic expression | |
EP0397560A3 (en) | Spheroidin dna isolate and recombinant entomopoxvirus expression vectors | |
AU5472896A (en) | Stabilized aqueous liquid preparations of blood coagulation factor XIII | |
NO172961C (en) | HERBICID PREPARATION AND USE THEREOF FOR CONTROL OF WEED GROWTH IN CORN CULTIVATION | |
DE3788852D1 (en) | Proteins with glutathione-S-transferase activity, DNA sequences, antibodies, poxviruses and drugs for the prevention of schistosomiasis. | |
ATE132900T1 (en) | GENES ENCODING A PROTEIN WITH HUMAN MACIF ACTIVITY, EXPRESSION VECTORS CONTAINING THESE GENES, TRANSFORMANT CELLS AND PROTEINS WITH HUMAN MACIF ACTIVITY | |
CA2066263A1 (en) | Tsh receptor | |
ATE209252T1 (en) | RECOMBINANT D-HYDANTOINASE, METHOD OF PREPARATION AND USE | |
EP0363127A3 (en) | Improvements in or relating to eukaryotic expression | |
AU3905893A (en) | Plant resistant to two or more viruses and preparation thereof | |
DE68923496D1 (en) | Process for the production of motilin-like polypeptides and its expression. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993922677 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993922677 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993922677 Country of ref document: EP |